Antithrombin Supplementation in Critically Ill Patients
Author Information
Author(s): Damien du Cheyron, Bruno Bouchet, Cédric Bruel, Cédric Daubin, Michel Ramakers, Pierre Charbonneau
Primary Institution: Caen University Hospital
Hypothesis
Does antithrombin supplementation improve filter lifespan during continuous renal replacement therapy in patients with septic shock?
Conclusion
Anticoagulation with unfractionated heparin plus antithrombin supplementation can prevent premature filter clotting in septic shock patients requiring continuous renal replacement therapy.
Supporting Evidence
- Patients receiving antithrombin had a longer median hemofilter survival time compared to those who did not.
- Antithrombin supplementation was associated with a decrease in clotting episodes.
- The study found no increase in bleeding risk with antithrombin supplementation.
Takeaway
Giving extra antithrombin to very sick patients helps keep their blood filters from getting clogged up too quickly.
Methodology
Retrospective case-control analysis of 106 patients with septic shock undergoing continuous renal replacement therapy over four years.
Potential Biases
Potential bias due to unmatched historical control groups.
Limitations
The study was single-center and retrospective, which may limit the generalizability of the findings.
Participant Demographics
Patients with septic shock, mean age 59.6 years, 66% male.
Statistical Information
P-Value
0.0045
Confidence Interval
95% CI 34.5 to 48.0
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website